Why is Clinitech Lab falling/rising?

As of 05-Sep, Clinitech Laboratory Ltd's stock is currently priced at Rs 52.37, reflecting an increase of Rs 1.37 or 2.69%. The stock has been gaining for the last two days, with a total return of 7.29% during this period. Despite this recent uptick, the stock has underperformed over the past week and year-to-date, showing declines of 0.25% and 33.59%, respectively. Additionally, the stock's delivery volume has significantly decreased by 78.26% against the 5-day average, indicating falling investor participation, which could impact future price movements.
Broader Market Context: In comparison to the Sensex, which has gained 1.13% over the past week and 3.29% year-to-date, Clinitech's performance has been notably weaker. While the stock has outperformed its sector today by 3.8%, its long-term performance remains concerning, with a year-over-year decline of 36.13%. This juxtaposition highlights the challenges Clinitech faces in regaining investor confidence, especially given the broader market's positive trajectory.